Your browser doesn't support javascript.
loading
Association of PD-L1 Expression on Tumor and Immune Cells with Survival in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Assay Validation.
Wildsmith, Sophie; Ye, Jiabu; Franks, April; Melillo, Giovanni; Armstrong, Jon; Whiteley, Jessica; Schnittker, Karina; Lian, Fangru; Roland, Bryan; Sabalos, Constantine; Ahmadi, Payam; Fayette, Jerome; Even, Caroline; Mesía, Ricard; Siu, Lillian L; Zandberg, Dan P; Walker, Jill.
Afiliação
  • Wildsmith S; Precision Medicine, R&D Oncology, AstraZeneca, Cambridge, United Kingdom.
  • Ye J; Statistics, AstraZeneca, Gaithersburg, Maryland.
  • Franks A; Global Medical Affairs, AstraZeneca, Gaithersburg, Maryland.
  • Melillo G; Global Medical Affairs, AstraZeneca, Gaithersburg, Maryland.
  • Armstrong J; Statistics, AstraZeneca, Macclesfield, United Kingdom.
  • Whiteley J; Precision Medicine, R&D Oncology, AstraZeneca, Cambridge, United Kingdom.
  • Schnittker K; Companion Diagnostics Development, Ventana Medical Systems, Tucson, Arizona.
  • Lian F; Companion Diagnostics Pathology, Ventana Medical Systems, Tucson, Arizona.
  • Roland B; Companion Diagnostics Project Lead, Ventana Medical Systems, Tucson, Arizona.
  • Sabalos C; Regulatory Affairs, Companion Diagnostics, Ventana Medical Systems, Tucson, Arizona.
  • Ahmadi P; Biometrics, Ventana Medical Systems, Tucson, Arizona.
  • Fayette J; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Even C; Head and Neck Oncology Department, CLCC Institut Gustave Roussy, Paris, France.
  • Mesía R; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO group, IGTP, Barcelona, Catalonia, Spain.
  • Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Zandberg DP; Department of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Walker J; Precision Medicine, R&D Oncology, AstraZeneca, Cambridge, United Kingdom.
Cancer Res Commun ; 2(1): 39-48, 2022 01.
Article em En | MEDLINE | ID: mdl-36860696

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Res Commun Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Res Commun Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido